Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids

J Kolenda, SS Jensen, C Aaberg-Jessen… - Journal of neuro …, 2011 - Springer
Tumor hypoxia has been attributed to play a crucial role in tumorigenesis and therapeutic
resistance. Recently, it has been suggested that hypoxia leads to and maintains the …

[HTML][HTML] Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas

RK Ramachandran, MD Sørensen, C Aaberg-Jessen… - PLoS …, 2017 - journals.plos.org
Astrocytomas are the most frequent primary brain tumors in adults, and despite aggressive
treatment patients often experience recurrence. Survival decreases with increasing tumor …

Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival

C Aaberg-Jessen, K Christensen, H Offenberg… - Journal of neuro …, 2009 - Springer
In colorectal cancer and breast cancer a high TIMP-1 level has been shown to correlate with
a shorter overall patient survival and it has been suggested that TIMP-1 is involved in …

miR-21 is linked to glioma angiogenesis: a co-localization study

…, BS Nielsen, C Aaberg-Jessen… - … of histochemistry & …, 2016 - journals.sagepub.com
MicroRNA-21 (miR-21) is the most consistently over-expressed microRNA (miRNA) in malignant
gliomas. We have previously reported that miR-21 is upregulated in glioma vessels and …

[HTML][HTML] Invasion of primary glioma-and cell line-derived spheroids implanted into corticostriatal slice cultures

C Aaberg-Jessen, A Nørregaard… - … journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Gliomas are highly invasive tumors and the pronounced invasive features of gliomas prevent
radical surgical resection. In the search for new therapeutics targeting invasive glioma cells…

[HTML][HTML] Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas

SS Jensen, C Aaberg-Jessen… - … journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Targeting of lysosomes is a novel therapeutic anti-cancer strategy for killing the otherwise
apoptosis-resistant cancer cells. Such strategies are urgently needed for treatment of brain …

[HTML][HTML] Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

C Aaberg-Jessen, MD Sørensen, ALSA Matos… - BMC cancer, 2018 - Springer
Background We have previously identified tissue inhibitor of metalloproteinases-1 (TIMP-1)
as a prognostic marker in glioblastomas. TIMP-1 has been associated with chemotherapy …

Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free …

K Christensen, C Aaberg-Jessen, C Andersen… - …, 2010 - journals.lww.com
OBJECTIVE: To investigate the influence of serum-free medium (SFM) supplemented with
epidermal growth factor and basic fibroblast growth factor compared with conventional serum-…

[HTML][HTML] Establishment and characterization of a tumor stem cell-based glioblastoma invasion model

…, B Halle, AM Rosager, C Aaberg-Jessen… - PloS one, 2016 - journals.plos.org
Aims Glioblastoma is the most frequent and malignant brain tumor. Recurrence is inevitable
and most likely connected to tumor invasion and presence of therapy resistant stem-like …

Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept

B Halle, EG Marcusson, C Aaberg-Jessen… - Journal of neuro …, 2016 - Springer
Over-expressed microRNAs (miRs) are promising new targets in glioblastoma (GBM) therapy.
Inhibition of over-expressed miRs has been shown to diminish GBM proliferation, invasion …